US Stock MarketDetailed Quotes

VIR Vir Biotechnology

Watchlist

7.340
-0.030-0.41%

Close Mar 11 16:00 ET

7.450
+0.110+1.50%

Post 16:32 ET

1.01BMarket Cap-1.92P/E (TTM)

Vir Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vir Biotechnology Q4 2024 Earnings Date

Currency：USDFeb 26, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	8.14M	12.37M	+4.23M
Beat Est.	-51.51%	-26.29%	+52.01%
EPS	-0.86	-0.76	+0.10
Beat Est.	+0.21%	+11.63%	+11.43%

Analyst Rating

Strong Buy

Mar 3, 2025

Vir Biotechnology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 6.792M	--
--	2025/Q1	-- / 8.592M	--
Feb 26, 2025	2024/Q4	12.374M / 8.140M	--
Oct 31, 2024	2024/Q3	2.380M / 5.510M	--
Aug 1, 2024	2024/Q2	3.075M / 7.497M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 6.792M--

--2025/Q1-- / 8.592M--

Feb 26, 20252024/Q412.374M / 8.140M--

Oct 31, 20242024/Q32.380M / 5.510M--

Aug 1, 20242024/Q23.075M / 7.497M--

Unlock Free Earnings Estimates

Open Account

Vir Biotechnology Earnings Reports

Vir Biotechnology | 10-K: FY2024 Annual Report

Feb 27 12:45 ET

Vir Biotechnology | 8-K: Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 26 16:24 ET

Vir Biotechnology | 10-Q: Q3 2024 Earnings Report

Nov 4, 2024 16:16 ET

Vir Biotechnology | 8-K: Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 31, 2024 16:26 ET